Advanced Practice Midwife in Tualatin, OR Accepting Medicare

4 Advanced Practice Midwife nurses found. Showing 1 - 4

Nicole M Rudy, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 19250 Sw 65th Ave Ste 300, Tualatin, OR 97062 Phone: 503-692-1242    Fax: 503-691-3615

Anna Luisa Raffaelli, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 19250 Sw 65th Ave Ste 300, Tualatin, OR 97062 Phone: 503-692-1242    Fax: 503-691-3615

Ms. Nancy Ann Macy, WHCNP CNM Advanced Practice Midwife Medicare: May Accept Medicare Assignments Practice Location: 19365 Sw 65th Ave Ste 105, Tualatin, OR 97062 Phone: 503-454-0018    Fax: 503-848-3471

Jane Elizabeth Adkins Nath, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 19250 Sw 65th Ave, Suite 300, Tualatin, OR 97062 Phone: 503-692-1242    Fax: 503-691-3615

News Archive

Research sheds light on genetic factors involved in autoimmune diseases

A collaboration between researchers at the Babraham Institute and the University of Manchester has mapped the physical connections occurring in the genome to shed light on the parts of the genome involved in autoimmune diseases. Using a new technique, called Capture Hi-C, the team revealed novel insights into how changes in the genetic sequence have a biological effect and increase the risk of disease.

Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals

Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that it has participated in a U.S. $3 million financing round of Avraham Pharmaceuticals Ltd. together with Pontifax, Clal Biotechnology Industries (CBI), Technion Research and Development Foundation Ltd. (TRDF), Professor Marta Weinstock-Rosin and others.

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

A team of researchers in the Department of Microbiology, Immunology and Pathology at Colorado State University aim to advance what is known about the complex immune response necessary to prevent tuberculosis disease.

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.

Nano Gen Teknolojileri to distribute Fluidigm's BioMark and EP1 genetic analysis systems in Turkey

Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.

Read more Medical News

› Verified 6 days ago